🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Open-label, multiple-dose, single-centre study in 2 groups of subjects: sub...
Status
Completed
Location
Farmovs-Parexel
Start Date
2005-05
Trial ID
NCT02281526
Treatments Being Tested
Open-label, single-dose (BIA 2-093 800 mg tablet), single-centre study in f...
Status
Completed
Location
Farmovs-Parexel
Start Date
2005-03
Trial ID
NCT02281422
Treatments Being Tested
The primary objective of the study is to assess the efficacy of eslicarbaze...
Status
Completed
Location
Multiple Locations
Start Date
2007-11
Trial ID
NCT00981227
Treatments Being Tested
The primary objective was to evaluate the efficacy of eslicarbazepine aceta...
Status
Completed
Location
Bial - Portela & Cª, S.A.
Start Date
2004-12
Trial ID
NCT00957372
Treatments Being Tested
Single centre, open-label, randomised, three-way crossover study in 18 heal...
Status
Completed
Location
CEB - Centre for Bioavailability Studies, AIBILI
Start Date
2004-02
Trial ID
NCT02279667
Single-centre, open-label, randomised, gender-balanced, 3-way crossover, 3-...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT02288312
Treatments Being Tested
There are a number of anti-epileptic drugs available for the treatment of p...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01587339
Treatments Being Tested
Multicentre, double-blind, randomised, parallel-group, placebo-controlled d...
Status
Completed
Location
Multiple Locations
Start Date
2005-12
Trial ID
NCT01822678
Treatments Being Tested
The purpose of this study is to investigate the efficacy and safety of esli...
Status
Completed
Location
BIAL - Portela & Cª, S.A.
Start Date
2010-12
Trial ID
NCT01162460
Treatments Being Tested
A dose randomized, double-blind, placebo controlled, single and multiple do...
Status
Completed
Location
Whan In Pharm.
Start Date
2019-08-22
Trial ID
NCT04095182